Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

Egypt: A recent randomized controlled trial has demonstrated that sitagliptin, a DPP-4 inhibitor, significantly improves ...

The enzyme dipeptidyl peptidase-4 (DPP-4) prevents the inactivation of glucagon-like peptide-1 (GLP-1). Since GLP-1-based therapy is a promising novel treatment of type 2 diabetes, the strategy to ...

Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of ...

New research presented at the ACG Annual Meeting suggests that GLP-1RAs lower the risk of pancreatic cancer in patients with ...

Rate this content's potential impact on patient outcomes Submit Rating Thank you! Please share some more information on the ...

The Director of Public Prosecutions (DPP) has officially withdrawn all charges against former Mungiki leader Maina Njenga. The announcement was made by Njenga’s lawyer Ndegwa Njiru on Monday, November ...

To have enough sway to pass legislation going forward, the ruling bloc has asked for help from the Democratic Party for the People (DPP), a small centrist group. The DPP has agreed to cooperate on a ...

To have enough sway to pass legislation going forward, the ruling bloc has asked for help from the Democratic Party for the ...

The Democratic Party for the People remains the third-largest opposition party in Japan, but its sharp gains in the Lower ...

To have enough sway to pass legislation going forward, the ruling bloc has asked for help from the Democratic Party for the ...

The Bank of Japan should avoid overhauling its ultra-loose monetary policy now, the head of a kingmaker opposition party said ...